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Comet assayDi(2-ethylhexyl)-phthalate (DEHP) is the most abundantly used phthalate derivative, inevitable environ-
mental exposure of which is suspected to contribute to the increasing incidence of testicular dysgenesis
syndrome in humans. Oxidative stress and mitochondrial dysfunction in germ cells are suggested to
contribute to phthalate-induced disruption of spermatogenesis in rodents, and Leydig cells are one of the
main targets of phthalates’ testicular toxicity. Selenium is known to be involved in the modulation of
intracellular redox equilibrium, and plays a critical role in testis, sperm, and reproduction. This study was
aimed to investigate the oxidative stress potential of DEHP and its consequences in testicular cells, and
examine the possible protective effects of selenium using the MA-10 mouse Leydig tumor cell line as a
model. In the presence and absence of selenium compounds [30 nM sodium selenite (SS), and 10 μM
selenomethionine (SM)], the effects of exposure to DEHP and its main metabolite mono(2-ethylhexyl)-
phthalate (MEHP) on the cell viability, enzymatic and non-enzymatic antioxidant status, ROS production,
p53 expression, and DNA damage by alkaline Comet assay were investigated. The overall results of this study
demonstrated the cytotoxicity and genotoxicity potential of DEHP, where MEHP was found to be more
potent than the parent compound. SS and SM produced almost the same level of protection against
antioxidant status modifying effects, ROS and p53 inducing potentials, and DNA damaging effects of the two
phthalate derivatives. It was thus shown that DEHP produced oxidative stress in MA-10 cells, and selenium
supplementation appeared to be an effective redox regulator in the experimental conditions used in this
study, emphasizing the critical importance of the appropriate selenium status., 1-chloro-2,4 dinitrobenzene.;
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Phthalic acid esters are the most abundantly produced plasticizers,
and known as endocrine disruptors and peroxisome proliferators
(PP). Their inevitable environmental exposures in humans have been
suspected to contribute to the increasing incidence of testicular
dysgenesis syndrome (TDS) that is a range of reproductive defects
including cryptorchidism and hypospadias in newborn boys, and
testicular cancer and reduced sperm quality in adult males (Swan,
2008). In fact, TDS has been shown to develop in male rats that are
exposed to phthalates in utero (Fisher et al., 2003). Di(2-ethylhexyl)-
phthalate (DEHP) is the most important phthalate derivative with its
high production, use and occurrence in the environment. It is mainly
used in polyvinyl chloride plastics in the form of numerous consumer
and personal care products and medical devices. The typical human
exposure to DEHP ranges from 3 to 30 μg/kg/day (Doull et al., 1999)
but, can be exceeded in speciﬁc medical conditions reaching 1.5 mg/
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kg/day during neonatal transfusion or parenteral nutrition (Loff et al.,
2000; Kavlock et al., 2005).
The mechanisms by which phthalates and speciﬁcally DEHP exert
their toxic effects in reproductive system are not yet fully elucidated.
Some of the effects of phthalate are related to their anti-androgenic
potential (Ge et al., 2007; Noriega et al., 2009). A peroxisome
proliferator-activated receptor α (PPARα)-mediated pathway based
on their PP activity (Gazouli et al., 2002), and activation of metabolizing
enzymes leading to free radical production and oxidative stress have
also been suggested (O'Brien et al., 2005). Although Sertoli cells were
thought to be theprimary targets of phthalate exposure in testis (Grasso
et al., 1993), available data suggest that Leydig cells are one of the main
targets (Ge et al., 2007). Leydig cells are the primary source of
testosterone production in males, and differentiation of Leydig cells in
the testes is one of the primary events in the development of the male
body and fertility (Zhang et al., 2008). Using the MA-10 mouse Leydig
tumor cell line as amodel systemmay, therefore, offer a valuablemodel
in studying the direct effects of environmental chemicals, particularly
those of endocrine disruptors on Leydig cell function in vitro. MA-10
cells are by far the best characterized and more widely used lines of
cultured Leydig tumor cells that were independently derived from the
M5480 tumor, a hormonally responsive mouse Leydig tumor (Ascoli,
1981).
The essential trace element selenium (Se), is the important
component of cellular antioxidant defense and is involved in the
modulation of intracellular redox equilibriumwith its some 25 forms of
cellular selenoproteins, particularly with glutathione peroxidases
(GPx), and thioredoxin reductases (TrxR) (Oberley et al., 2000). Se is
actively involved in many fundamental biological processes ranging
from immune functions to apoptosis, and protection and repair of DNA
(Ganther, 1999). It is essential for theproductionof normal spermatozoa
and thus plays a critical role in testis, sperm, and reproduction (Flohé,
2007). The major role of Se in fertility is mediated by the membrane
bound phospholipid hydroperoxide glutathione peroxidase (GPx4)
which is the most abundant selenoprotein in testis (Flohé, 2007; Ursini
et al., 1999). Testis Se is known to be remarkably and preferentially
maintained in Se deﬁciency. Severe and prolonged deﬁciency results in
sterility as spermatogenesis was arrested, whereas in less severe Se
deprivation reduced sperm motility leading to impaired fertilization
capacity and abnormal sperm morphology were reported (Maiorino et
al., 2006). On the other hand, epidemiological studies have suggested
that low serum Se levels were associated with an increase in the
incidence of cancer (Clark et al., 1991). The chemopreventive and
chemotherapeutic mechanisms of Se still remain unclear. Protection
against oxidative damage, induction of apoptosis secondary to produc-
tion of reactive oxygen species (ROS), and regulation of the thioredoxin
(Trx) redox system are among the many potential mechanisms
proposed (Combs and Gray, 1998; Ganther, 1999; Kitahara et al.,
1993) which also seem to be closely related to the roles of Se in the
reproductive system.
Oxidative stress and, thus, ROS play an important role in the
modulation of several important physiological functions, but also
accounts for changes that can be detrimental to the cells (Dröge,
2002). ROS are shown to contribute to cellular damage, apoptosis and
cell death, but also involved in regulation of gene expression by
controlling signal transduction through direct participation in cell
signaling, and/or modulation of cell redox state (Dalton et al., 1999;
Finkel, 1998). ROS have also been suspected of being involved in the
formation of testicular atrophy in phthalate-exposed rats (Kasahara et
al., 2002). On the other hand, p53 tumor suppressor protein is a redox
sensitive protein known to play important roles in controlling the
integrity and correctness of all processes in each individual cell.
Activation of p53 by ROS and exogenous DNA damages can lead to
growth arrest of the cell, DNA repair induction or apoptosis (Kim et al.,
2009). Several environmental chemicals including phthalates havebeen shown to induce apoptosis in the reproductive tract of rodents
through p53 induction (Chandrasekaran and Richburg, 2005).
On thebasis of these knowledge and available data, it seemsuseful to
examine modulation of cellular redox by Se and whether Se supple-
mentation is effective on the effects of phthalates in rat reproductive
system. In the current study, MA-10 mouse Leydig cells cultured with
and without Se supplementation were used as a model, and the effects
of exposure to DEHP and its major metabolite MEHP on the viability,
enzymatic and non-enzymatic antioxidant status, ROS production, p53
expression and DNA damage were investigated.
Materials and methods
Chemicals. MEHP was obtained from Cambridge Isotope Laborato-
ries® (Andover, MA, USA). The protein assay kit was from Uptima
Interchim® (Montluçon, France). NaOH was purchased from Carlo
Erba® (Rodano, Italy). Dulbecco'smodiﬁed Eaglemedium (1:1) nutrient
mixture (DMEM/F-12) was purchased from Gibco® (Courbevoie,
France). 5-(and 6-) chloromethyl-2’,7’-dichlorodihydroﬂuorescein
diacetate (CM-H2DCFA) was purchased from Molecular Probes De-
tection Technologies, Invitrogen® (Eugene, OR, USA). The EnVision
Plus staining kit was purchased from Dako® (Carpinteria, CA, USA).
All the other chemicals including DEHP, sodium selenite (SS),
selenomethionine (SM), dimethyl sulfoxide (DMSO), 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), 5,5′-dithiobis
(2-nitrobenzoic) acid (DTNB), 1-chloro-2,4 dinitrobenzene (CDNB), fetal
bovine serum (FBS), Mayers hematoxylin nuclear stain, and saponin
from quillaja bark; colorimetric assay kits for thioredoxin reductase
(TrxR), and glutathione (GSH) measurements; Cell Lytic M cell lysis
reagent, protease inhibitor cocktail, were obtained from Sigma-Aldrich®
(St. Louis, MO, USA). Anti-p53, the mouse monoclonal antibody, sc-263
was obtained from Santa Cruz Biotechnology Inc® (Santa Cruz,
California, USA). The goat anti-mouse horseradish peroxidase (HRP)
conjugated secondary antibody was purchased from Invitrogen Molec-
ular Probes® (Oregon, USA).
Cell culture and treatment. MA-10mouse Leydig tumor cells were a
generous gift from Prof. Mario Ascoli (Department of Pharmacology,
University of Iowa College, Iowa City, USA) and maintained in
Waymouth medium containing 15% (v/v) heat-inactivated horse
serum, and 50 μg/mL gentamicin as previously described (Ascoli,
1981). Culturing of the MA-10 cells were accomplished in DMEM/F-
12 (1:1) medium supplemented with 15% horse serum and
gentamicin (50 μg/ml) using gelatin-coated culture ﬂasks, at 37 °C
in a humidiﬁed incubator under 5% CO2. For sub-cultivation cells were
trypsinized, washed with sterile phosphate-buffered saline (PBS) and
centrifuged at 1500× g for 5 min. For the experiments only the cells of
10–12 passages were used.
SS and SM stock solutionswere prepared in sterile, deionized water.
DEHP (50 mM) and MEHP (100 μM) stock solution were prepared in
0.1% DMSO, and fresh dilutions were made using culture medium to
achieve ﬁnal concentrations ranging from 1 to 10 mM for DEHP and
from 1 to 10 μM forMEHP. Cell viabilitymeasurementswere performed
inMA-10 cells incubated with various concentrations of DEHP orMEHP
for 24 h. For the assessment of protective effect of Se, MA-10 cells
supplementedwith 30 nM SS or 10 μMSMwere cultured for 72 h, then
exposed to various concentrations of DEHP or MEHP for 24 h while
continuing the Se supplementation. The doses of Se in the formof SS and
SM used in this study were chosen from preliminary experiments (not
shown) as concentrations do not inhibit cell growth and do not cause
cytotoxicity, but result in maximal GPx1 induction after 72 h of
incubation.
For the measurement of enzyme activities, ROS and total GSH
levels, p53 expression, and for alkaline single-cell gel electrophoresis
(SCGE, Comet assay), following treatment groups of MA-10 cells were
prepared: Non-treated cells (NT-C): MA-10 cells were cultured
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cells were cultured with 30 nM SS for 72 h; SM-supplemented cells
(SM-S): MA-10 cells were cultured with 10 μM SM for 72 h; DEHP-
treated cells (DEHP-T): MA-10 cells were cultured with 3 mM DEHP
for 24 h; DEHP-treated SS-S cells (SS/DEHP-T): SS-S cells were
cultured with 3 mM DEHP for 24 h; DEHP-treated SM-S cells (SM/
DEHP-T): SM-S cells were cultured with 3 mM DEHP for 24 h; MEHP-
treated cells (MEHP-T): MA-10 cells were cultured with 3 μM MEHP
for 24 h; MEHP-treated SS-S cells (SS/MEHP-T): SS-S cells were
cultured with 3 μM MEHP for 24 h; MEHP-treated SM-S cells (SM/
MEHP-T): SM-S cells were cultured with 3 μM MEHP for 24 h.
Determination of cell viability. Cell viability was determined by a
modiﬁed MTT assay (Cory et al., 1991), in conjunction with trypan blue
counting. 3000 cells per well were plated onto 96-well microtiter plates
in 200 μL medium with or without DEHP, MEHP, SS or SM. After
incubation for speciﬁed times at 37 °C in a humidiﬁed incubator, the
medium was removed, cells were washed twice with PBS and 20 μL of
MTT (5 mg/mL in PBS) was added to each well. The medium was
removed 2 h later, 200 μL of DMSO was added to dissolve the formazan
product and the absorbancewas read at 570 nmusingMultiscan Ascent
microtiter plate reader (Labsystems, France). The absorbance was
proportional to viable cell number, and cell survival was calculated as
the percentage of the staining values of untreated cultures. The
percentage viability was calculated as “% speciﬁc viability=[(A − B)/
(C − B)]/100” where A=absorbance of the treated cells at 570 nm,
B=absorbance of the medium at 570 nm, and C=absorbance of the
control cells at 570 nm.
Antioxidant enzyme assays and glutathione levels. After speciﬁed
incubation periods and trypsinization, cells were lysed using Cell
Lytic M Cell Lysis agent with a protease inhibitor cocktail, and then
centrifuged at 4000 rpm, 4 °C for 10 min. After further centrifugation
at 13.000 rpm, 4 °C, for 20 min, antioxidant enzyme activities and GSH
levels were measured in the supernatant.
The activity of cytosolic GPx (GPx1) was measured in a coupled
reaction with glutathione reductase (GR) as described earlier (Flohé
and Günzler, 1984; Günzler et al., 1974). The assay is based on the
instant and continous reduction of oxidized glutathione (GSSG)
formed during GPx1 reaction by an excess of GR activity providing
for a constant level of GSH. As a substrate, t-butyl hydroperoxide used
and concominant oxidation of NADPH was monitored spectrophoto-
metrically at 340 nm. One unit of enzyme was deﬁned as the amount
of GPx1 that transformed 1 μmol of NADPH to NADP per minute at
37 °C.
Cytosolic TrxR activity was determined colorimetrically using
Thioredoxin Reductase Assay kit. As described previously (Arner et al.,
1999), the method is based on the reduction of DTNB with NADPH to
5-thio-2-nitrobenzoic acid (TNB) that is measured at 412 nm. One
unit of TrxR activity was deﬁned as the enzyme that caused an
increase in A412 of 1.0 per minute per mL at pH 7.0 at 25 °C.
Cytosolic glutathione-S-transferase (GST) activity was determined
according to the method of Habig et al. (1974) using CDNB as a
substrate and measuring the change in absorbance at 340 nm. The
results were given as nmol/min/mg protein.
For the measurement of the total GSH levels, cells were diluted
with 5-sulphosalicylic acid for protein precipitation, and centrifuged
at 4000 rpm, 4 °C, for 10 min. Supernatants were used for total GSH
determinations by using Glutathione Assay kit. The assay was based
on the reduction of DTNB by NADPH by a reaction catalyzed by GR
using GSH at 412 nm (Akerboom and Sies, 1981). The results were
given as pmol GSH/mg protein.
Protein content of the samples was determined by bicinchoninic
acid assay (BCA) using a protein assay kit (Krieg et al., 2005). The
results were given as mg/mL protein.Measurement of intracellular ROS production. Total intracellular ROS
production was measured using peroxide sensitive ﬂuorescent probe
CM-H2DCFA as described earlier (Loikkanen et al., 1998). The studywas
conducted in the dark, and 70–80% conﬂuent cells were used. MA-10
cells seeded in 96-well plateswith/without SS (30 nM) and SM(10 μM)
incubated at 37 °C in a humidiﬁed incubator under 5% CO2 for 72 h.
After removal of the culture media, cells were loaded with CM-H2DCFA
in PBS buffer for 30 min at room temperature. The cellular esterase
activity results in the formation of the nonﬂuorescent compound, the
2′,7′-dichloroﬂuorescin (DCFH). DCFH is rapidly oxidized in the
presence of ROS to a highly ﬂuorescent 2′,7′-dichloroﬂuorescein
(DCF). The cells were washed, then incubated with with/without
DEHP (3 mM) orMEHP (3 μM) at 37 °C in a humidiﬁed incubator under
5% CO2 for 0, 30 and 60 min. DCF ﬂuorescence was measured with a
PerkinElmer Victor 3 1420 multiwell ﬂuorometer (Perkin Elmer®,
Buckinghamshire, UK) at an excitation wavelength of 485 nm and an
emission wavelength of 535 nm. After data acquisition, Wallac 1420
Manager software was used to analyze ROS production. Background
ﬂuorescence was obtained from cell-free wells containing 5 μM DCF in
0.5 mL of PBS and subtracted from the ﬂuorescence values found. The
multiwell plate was kept in a cell culture incubator between the
measurements. The exposures were repeated 3–4 times with three
parallelmeasurements. Fluorescence valueswere normalized to the cell
numbers. For each condition, 8-wells with triplicate measurements
were used and the mean of three independent experiments was given
as a result.
p53 evaluation by immunocytochemistry. The expression of p53 in
MA-10 cells was examined immunocytochemically using the EnVision
Plus System. MA-10 cells, treated and cultured as described above,
were washed with PBS for 3 min shaking on a shaker gently, and ﬁxed
with 4% formaldehyde in PBS at room temperature. Cells were rinsed
with ddH20 once, and washed with PBS for 3 min as were done
between each step, then permeabilized with PBS/0.5% saponin/0.3%
Triton X-100 for 3 times, each 5 min on the shaker. Cells were blocked
with PBS/%10 FBS/0,3% Triton X-100 at 37 °C for 1 h, then PBSwashed
cells were incubated with diluted primary antibody overnight at 4 °C.
Secondary antibody was used directly and cells were incubated at
25 °C for 30 min. Cells were again washed with 1× PBS and later with
1× PBS/2% FBS/0,3% Triton X-100 3 times, and stained with 3,3'-
diaminobenzidine (DAB) Chromogen solution. The staining was
stopped by adding ddH20, and then hematoxylin was used as a
nuclear stain. Images were acquired with a DC490 digital camera
(Leica, Wetzlar, Germany). Cells were considered to be positive when
the brown staining was present in the nucleus. For each condition 3
slides were counted and the results were given as percentage of p53
nuclear stainings.
Alkaline single-cell gel electrophoresis (Comet assay). DNA damage
was evaluated using the alkaline Comet assay that allows the
measurement of single- and double-strand breaks together with
alkali-labile sites. The assay was performed as described earlier (Singh
et al., 1988; Tice et al., 2000) and measurements were made in two
consecutive days on triplicate slides and the results were given as the
mean value of the two days. Immediately after the treatments, the
cells were isolated, washed and re-suspended in PBS at a density of
~2.5×106 cells/ml. 50 μl of this suspension was mixed with 450 μl
solution of low melting point agarose (0.6% in PBS), and 100 μl of the
solution was spread on a microscope slide covered with 1% agarose.
Cells were lysed (2.5 M NaCl, 0.5 M Na2-EDTA, 10 mM Tris, 1% sodium
lauryl sulfate, 1% Triton X-100, 10% DMSO, pH 10) at 4 °C in the dark
for 1 h. After lysis, cells were immersed in freshly prepared alkaline
electrophoresis buffer (300 mM NaOH, 1 mM Na2-EDTA, pH 13) for
30 min to allow DNA unwinding. Electrophoresis was then performed
at 25 V/300 mA for 30 min. Slides were rinsed three times for 5 min
with neutralization buffer (0.4 M Tris-HCl, pH 7.4), and stained with
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microscope (Carl Zeiss®, Germany) was used which was connected to
a charge-coupled device (CDC) and a computer-based analysis system
(Comet assay IV software, Perceptive Instruments Ltd), and the extent
of DNA damage was determined after electrophoretic migration of
DNA fragments in the agarose gel. For each condition, 50 randomly
selected comets on each slide were scored, and the tail% intensities
(percentage of DNA in the tail) and the tail moments (product of
comet length and tail intensity) were determined as an average of
triplicate slides.
Statistical analysis. The data were expressed as mean±standard
error (SEM). Statistical signiﬁcances of differences among treatment
groups were determined by use of one-way analysis of variance and
covariance (ANOVA), followed by Student's t-test using a Statistical
Package for Social Sciences Program (SPSS). A p-valueb0.05 was
considered as statistically signiﬁcant.Fig. 1. Cell viability in phthalate-exposed MA-10 mouse Leydig tumor cell line, and protecti
data were presented as relative to zero dose of DEHP or MEHP. Values are given as mean±
various concentrations of DEHP on MA-10 Leydig cells cultured with or without selenium
supplemented and cultured with 30 nM SS for 72 h; SM-S: MA-10 cells supplemented and cu
of DEHP for 24 h; SS/DEHP: SS-S cells cultured with various concentrations of DEHP for 24
apb0.05 vs. NT-C, bpb0.05 vs. DEHP. B. Cytotoxicity of various concentrations of MEHP e
MEHP: MA-10 cells cultured with various concentrations of MEHP for 24 h; SS/MEHP: SS-
cultured with various concentrations of MEHP for 24 h. apb0.05 vs. NT-C, bpb0.05 vs. MEHResults
Cell viability
In Fig. 1, cell viability data produced by MTT assay for DEHP-, and
MEHP-treated MA-10 cells were presented as relative to zero dose of
DEHP or MEHP. DEHP had a ﬂat dose-cell viability response curve, so
that MA-10 cells showed ~80 to 60% survival at a dose range of 10 μM
to 0.5 mM DEHP (Fig. 1A). Whereas MEHP was highly toxic at μM
range with a very sharp dose-response curve, so that there was no cell
survival at doses 10 μM and higher (Fig. 1B). The IC50 values for DEHP
and MEHP were found to be approximately 3 mM and 3 μM,
respectively. This demonstrated that MEHP, the main metabolite of
DEHP, was themain active form inMA-10 cells with an almost ~1000-
fold higher cytotoxicity than the parent compound.
Se supplementation of the cells with either SS (30 nM) or SM
(10 μM)wasprotective against the cytotoxic effects ofDEHP, andMEHP.ve effect of selenium supplementation. Cell viability was determined by MTT assay and
SEM of n=3 independent experiments and triplicate measurements. A. Cytotoxicity of
supplementation. NT-C: non-treated MA-10 cells cultured for 72 h; SS-S: MA-10 cells
ltured with 10 μM SM for 72 h; DEHP: MA-10 cells treated with various concentrations
h; SM/DEHP: SM-S cells cultured with various concentrations of DEHP for 24 h. 24 h.
xposure on MA-10 Leydig cells cultured with or without selenium supplementation.
S cells cultured with various concentrations of MEHP for 24 h; SM/MEHP: SM-S cells
P.
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protective providing ≥50% higher viability, and the effects of SS was
higher (pb0.05) than SM at 0.2, 0.5 and 1 mMDEHP exposures. In cells
exposed to an IC50 dose of DEHP, both SS and SM forms of Se provided
higher viability (~36 and 48%, respectively, pN0.05) than DEHP-treated
cells (Fig. 1A). Whereas a complete viability as control cells was
observed with SM supplementation in MA-10 cells exposed to an IC50
dose of MEHP (Fig. 1B), supplementation with SS maintained the cell
viability at a level of ~85%of control cells (NT-C), and thedifferenceof SS
and SM effects was signiﬁcant (pb0.05).
Enzymatic and non-enzymatic antioxidants
The results of the antioxidant status assessment of MA-10 cells are
illustrated in Fig. 2. Se supplementation of MA-10 cells with either SS
or SM (that is SS-S and SM-S cells) signiﬁcantly increased the
activities of GPx1 (1.7- and 1.6-fold, respectively) and TrxR (~1.6- and
1.7-fold, respectively) compared to non-treated control cells (NT-C);
but did not cause any change on the total GSH level and GST activity.
The difference between the effects of SS and SM was insigniﬁcant.
In cells exposed to DEHP or MEHP, GPx1 activity decreased ~2.5
and ~4-fold, respectively (Fig. 2A). Thus, the effect of MEHPwasmuch
higher. Se supplementation either with SS or SM in DEHP-exposed
cells was able to enhance the GPx1 activity signiﬁcantly even up to
those of SS-S and SM-S cells. In MEHP-exposed cells, SS supplemen-
tation maintained the GPx1 activity almost at the control level,Fig. 2. Enzymatic and non-enzymatic antioxidant status in DEHP- or MEHP-treated MA-10
C. GST activity. D. Total GSH level. Values are given as mean±SEM of n=3 independent expe
are signiﬁcantly different from each other (pb0.05). Measurements were performed in the
SS-S: MA-10 cells supplemented and cultured with 30 nM SS for 72 h; SM-S: MA-10 cells su
3 mMDEHP for 24 h; SS/DEHP-T: SS-S cells cultured with 3 mMDEHP for 24 h; SM/DEHP-T:
MEHP for 24 h; SS/MEHP-T: SS-S cells cultured with 3 μM MEHP for 24 h; SM/MEHP-T: SMwhereas the effect of SM was signiﬁcantly higher than that of SS,
elevating the activity of GPx1 to the level of SM-S cells.
The same level of decrease (~2.4-fold) was observed in cytosolic
TrxR activity of MA-10 cells exposed to the parent phthalate or the
main metabolite (Fig. 2B). Supplementation of Se with SS was able to
elevate the cytosolic TrxR activity of MEHP-exposed cells to the levels
of SS-S cells, and with SM to the level of control cells. However, in
DEHP-exposed cells, the increase of TrxR activity with Se supplemen-
tation was rather low reaching only ~75–80% of that of control cells.
GST activity also decreased signiﬁcantly in DEHP-T (60%) and
MEHP-T (53%) cells. Neither SS nor SM supplementation restored the
activity of the cytosolic GST in phthalate-exposed cells. In contrast, Se
supplementation in both SS and SM forms decreased the enzyme
activity in MEHP-exposed cells. Whereas, GST activity remained the
same with the presence of SS, but was found even lower with SM
supplementation in DEHP-exposed cells (Fig. 2C).
Total GSH levels decreased signiﬁcantly in DEHP-T (~40%) and
MEHP-T (~42%) cells (Fig. 2D). Se supplementation provided signiﬁcant
restoration in both groups elevating the GSH content up to ~75–80% of
the NT-C levels.
ROS production
Fig. 3 illustrates the intracellular production of ROS in MA-10 cells
at different time points. As shown in Fig. 3A, there was no signiﬁcant
ROS production in NT-C cells at time point 30 min, but after 60 min ofLeydig cells and effects of selenium supplementation. A. GPx1 activity. B. TrxR activity.
riments and triplicate measurements. Bars that do not share same letters (superscripts)
following treatment groups of cells: NT-C: non-treated MA-10 cells cultured for 72 h;
pplemented and cultured with 10 μM SM for 72 h; DEHP-T: MA-10 cells cultured with
SM-S cells cultured with 3 mMDEHP for 24 h; MEHP-T: MA-10 cells cultured with 3 μM
-S cells cultured with 3 μM MEHP for 24 h.
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SM forms did not change the intracellular ROS levels when compared
to NT-C cells neither after 30 min nor 60 min of incubations.
DEHP and MEHP exposures caused strongly ampliﬁed production
of ROS. At time point 30 min, ROS levels of the DEHP-exposed cells
increased signiﬁcantly, reaching ~2.4-fold of the level of time zero,
and after 60 min of incubation the increase was ~3.5-fold (Fig. 3B).
Whereas in MEHP-treated MA-10 cells, very sharp elevation of ROS
production was observed reaching ~2.3-fold and ~11.4-fold of the
initial level, at time points 30 min and 60 min, respectively (Fig. 3C).Fig. 3. ROS production in DEHP- or MEHP-exposed MA-10 Leydig cells and effects of
selenium supplementation. Total intracellular ROS was measured using peroxide
sensitive ﬂuorescent probe CM-H2DCFA at 0, 30, and 60 min. Values are given asmean±
SEM of n=3 independent experiments and triplicate measurements. Bars that do not
share same letters (superscripts) are signiﬁcantly different from each other (pb0.05).
A. ROS production in cells without phthalate exposure (NT-C: non-treated MA-10 cells
cultured for 72 h; SS-S: MA-10 cells supplemented and culturedwith 30 nM SS for 72 h;
SM-S: MA-10 cells supplemented and cultured with 10 μM SM for 72 h). B. ROS
production in DEHP-treated cells (DEHP-T: MA-10 cells cultured with 3 mM DEHP for
24 h; SS/DEHP-T: SS-S cells cultured with 3 mMDEHP for 24 h; SM/DEHP-T: SM-S cells
cultured with 3 mMDEHP for 24 h). C. ROS production in MEHP-treated cells (MEHP-T:
MA-10 cells cultured with 3 μM MEHP for 24 h; SS/MEHP-T: SS-S cells cultured with
3 μMMEHP for 24 h; SM/MEHP-T: SM-S cells cultured with 3 μMMEHP for 24 h).Both SS and SM supplementations were highly effective against
the generation of intracellular ROS induced by both phthalate
derivatives. In the presence of SS, ROS levels in DEHP-exposed cells
decreased ~2-fold and ~2.2-fold, at 30 and 60 min, respectively.
Whereas, the decrease with SM supplementation was ~1.4-fold at
both time points (Fig. 3B).
InMEHP-T cells, SS supplementation caused ~3.5-fold and ~1.8-fold
decrease of ROS production at 30 min and 60 min, respectively.
Whereas presence of Se in SM form provided ~2.6-fold and ~2.1-fold
decrease of ROS generation at 30 min and 60 min, respectively (Fig. 3C).
p53 immunocytochemistry
As shown in Table 1, p53 protein expression in Se treated MA-10
cells was signiﬁcantly lower (~65%) than the steady state level of the
control cells (NT-C), and there was no difference between the
protective effects of SS and SM. In MA-10 cells exposed to an IC50
dose of DEHP, p53 expression was not induced. But a signiﬁcant
induction (~1.7-fold) of p53 expression was observed in MA-10 cells
exposed to an IC50 dose of MEHP. SS or SM supplementation enabled
the phthalate-exposed cells to maintain the p53 expression almost at
the basal level, or even lower as in the case of SS/DEHP-T cells. Fig. 4
shows the images of p53 expression in MEHP-treated cells along with
the images of control groups.
DNA damage—Comet assay
Fig. 5 shows the results of the alkaline Comet assay performed on
MA-10 cells exposed to an IC50 dose of DEHP (3 mM) or MEHP (3 μM)
in the presence or absence of Se, with the illustrations of the examples
of comet images.
Both DEHP and MEHP produced high level of DNA damage as
evidenced by signiﬁcantly increased tail intensity (%) (~3.4-fold and
~3.8-fold, respectively), and tail moment (~4.2-fold and ~3.8-fold,
respectively) compared to non-treated MA-10 cells. The difference
between the DNA damaging effects of the parent compound and the
metabolite was insigniﬁcant.
Se supplementation itself did not cause any alteration on the
steady state levels of the DNA damage biomarkers of MA-10 cells. But
Se was highly effective to decrease the genotoxic effects of phthalate
esters. Increased tail % intensities by DEHP and MEHP exposure were
lowered ~50–55% with SS supplementation, whereas SM treatmentTable 1
p53 immunocytochemistry scorings for the study groups.
Study group % of nuclear p53 stained cells
NT-C 8.77a
SS-S 2.99b
SM-S 3.14b
DEHP-T 9.38a
SS/DEHP-T 6.72c
SM/DEHP-T 8.76a
MEHP-T 15.03d
SS/MEHP-T 8.86a
SM/MEHP-T 9.85a
p53 expression was determined using EnVision Plus staining kit as described in
Materials and Methods. Results were given as the percentage of p53 nuclear staining
(mean ± SEM). Means that do not share same letters (superscripts) are signiﬁcantly
different from each other (pb0.05).
Measurements were performed in the following treatment groups of cells: NT-C: non-
treated MA-10 cells cultured for 72 h; SS-S: MA-10 cells supplemented and cultured
with 30 nM SS for 72 h; SM-S: MA-10 cells supplemented and cultured with 10 μM SM
for 72 h; DEHP-T: MA-10 cells cultured with 3 mM DEHP for 24 h; SS/DEHP-T: SS-S
cells cultured with 3 mM DEHP for 24 h; SM/DEHP-T: SM-S cells cultured with 3 mM
DEHP for 24 h; MEHP-T: MA-10 cells cultured with 3 μM MEHP for 24 h; SS/MEHP-T:
SS-S cells cultured with 3 μM MEHP for 24 h; SM/MEHP-T: SM-S cells cultured with
3 μM MEHP for 24 h.
Fig. 4. Immunocytochemistry of p53 expression, using EnVision Plus staining kit, in MEHP-treated MA-10 Leydig cells in the presence and absence of selenium p53 was visualized as
brown precipitate in the nucleus of the cells. Arrows indicate MA-10 cells with p53 positive staining. For each condition 3 slides were counted and the results were given as the
percentage of p53 nuclear staining. The images represent the p53 protein of the following treatment groups of cells: NT-C: non-treated MA-10 cells cultured for 72 h; SS-S: MA-10
cells supplemented and cultured with 30 nM SS for 72 h; SM-S: MA-10 cells supplemented and cultured with 10 μM SM for 72 h; MEHP-T: MA-10 cells cultured with 3 μMMEHP for
24 h; SS/MEHP-T: SS-S cells cultured with 3 μM MEHP for 24 h; SM/MEHP-T: SM-S cells cultured with 3 μM MEHP for 24 h.
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DEHP- or MEHP-exposed cells by ~55–65%, whereas the protective
effect of SM on tail moments was signiﬁcantly lower than SS as being
~45% and ~34% for the effects of DEHP and MEHP, respectively.
However, both SS and SM reduced the tail moments of the DEHP- and
MEHP-exposed cells down to the levels that were not signiﬁcantly
different than that of control cells.Discussion
DEHP is a well-known peroxisome proliferator, and regarded as a
non-classic type endocrine disruptor, that is, in contrast to the classical
endocrine disrupters which interfere with endocrine process at the
receptor level, alters reproductive function by affecting hormone
synthesis (Akingbemi et al., 2004; Gazouli et al., 2002; Wilson et al.,
2004). Exposures toDEHPor itsmainmetaboliteMEHPhavebeen found
to result in decreased testicular testosterone levels in mice, indicating
that testosterone producing Leydig cells were also the target of the
phthalates, besides Sertoli cells (Jones et al., 1993). In fact, inhibition of
LH-stimulated testosterone secretion by MEHP in MA-10 Leydig cells
was previously demonstrated (Freeman and Ascoli, 1983; Gazouli et al.,
2002), and co-administration of testosterone with DEHP was reported
to prevent the DEHP-induced testicular toxicity (Parma et al., 1987).The induction of oxidative stress was previously suggested to
represent a common mechanism in endocrine disruptor-mediated
dysfunction, speciﬁc to certain testicular cells (Latchoumycandane and
Mathur, 2002). Recent data have also shown that phthalates were able
to produce free radicals by several pathways in germ cells including
activation of PPARα, suggesting the possibility that oxidative stress
and mitochondrial dysfunction in germ cells may contribute to
phthalate-induced disruption of spermatogenesis (Gazouli et al.,
2002; Suna et al., 2007). DEHP treatment, indeed, was reported to
provoke oxidative stress as measured by increases in ROS in
subsequently isolated rat spermatocytes (Kasahara et al., 2002).
MEHP was reported to increase peroxiredoxin 3 and cyclooxygenase-
2 levels in germ cells indicating that the disruption of cellular redox
mechanisms in spermatocytes (Onorato et al., 2008). Thus, at least one
of themechanismsunderlying the reproductive toxicity of DEHPmight
be the induction of intracellular ROS and/or to cause alterations on
intracellular enzymatic and non-enzymatic antioxidants, thereby to
produce oxidative stress.
In the current study, using a well-established cell model, the MA-
10 mouse Leydig tumor cell line (Ascoli, 1981), the effects of direct
exposure to DEHP and MEHP on Leydig cells, including cytotoxicity,
genotoxicity and oxidative stress potential were investigated. MA-10
cells produce more progesterone than testosterone, but otherwise
resemble normal Leydig cells (Mylchreest et al., 2002). They contain
Fig. 5. Results of alkaline Comet assay in DEHP- or MEHP-treated MA-10 Leydig cells and effects of selenium supplementation. A. Typical images of Comets. B. Tail % intensities and tail
moments as ameasure of DNAdamage. Values are given asmean±SEMof n=2 independent experiments and triplicatemeasurements. Bars that donot share same letters (superscripts)
are signiﬁcantly different fromeach other (pb0.05).Measurementswere performed in the following treatment groups of cells: NT-C: non-treatedMA-10 cells cultured for 72 h; SS-S:MA-
10 cells supplemented and cultured with 30 nM SS for 72 h; SM-S: MA-10 cells supplemented and cultured with 10 μM SM for 72 h; DEHP-T: MA-10 cells cultured with 3 mM DEHP for
24 h; SS/DEHP-T: SS-S cells culturedwith 3 mMDEHP for 24 h; SM/DEHP-T: SM-S cells culturedwith 3 mMDEHP for 24 h;MEHP-T:MA-10 cells culturedwith 3 μMMEHP for 24 h; SS/
MEHP-T: SS-S cells cultured with 3 μMMEHP for 24 h; SM/MEHP-T: SM-S cells cultured with 3 μMMEHP for 24 h.
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case of both Leydig and Sertoli cells of adult rats (Braissant et al.,
1996).
Cytotoxicity, in the current study, was assessed using the MTT
assay of mitochondrial integrity, a marker of cell viability. Signiﬁ-
cantly decreased cell viability was observed with 10 μM and higher
concentrations of DEHP. However, in agreement with earlier reports
(Kambia et al., 2004), and with the results of our recent study
conducted on LNCaP cells (Erkekoglu et al., 2010), cytotoxicity of
MEHP was much higher than the parent compound, indicating the
toxicity of DEHP is mostly based on the activity of MEHP. In fact, the
difference between the IC50 values of the two agents was almost three
orders of magnitude. However, the toxicity range of MEHP reported
by two studies was signiﬁcantly different than ours. Dees et al. (2001)
examined the effects of various concentrations of MEHP on proges-
terone production, cell viability, protein content and cell morphology
in MA-10 cells in the presence of hCG, and they observed no effect for
the range of 0.3 μM to 1 mM MEHP, and markedly decreased cell
viability (to 16%) at 3 mM -10 mM. In a very recent study which was
published during the submission of the present study, it was also
reported that at concentrations as high as 300 μM, MEHP was not
toxic to the MA-10 cells (Fan et al., 2010). The reason for this
discrepancy is not known, however, might be due to the differences in
the experimental designs, the cell culturing conditions, particularly
cell density/number, and source and purity of the MEHP, and may be
the presence or absence of hCG.
Se supplementation was highly effective in maintaining the
viability of MA-10 cells exposed to various doses of DEHP, and
MEHP. The protective effect of 30 nM SS supplementation on the cellsurvival was almost as the same level as the protection provided by 10
μM SM. Thus, more SM was required to achieve a similar effect as was
obtained with the more bioavailable form of Se, selenite. The doses of
Se in the form of SS and SM used in this study were chosen from
preliminary experiments (not shown) as the concentrations did not
inhibit cell growth and did not cause cytotoxicity, but result in
maximal GPx1 induction after 72 h of incubation. These concentra-
tions were also in the same range as those concentrations of SS and
SM that were shown previously with the same properties for several
other cell types (Bhamre et al., 2003; Chu et al., 1990; Mansur et al.,
2000). SS is commonly used for cell culture and animal studies, and
SM is the most common form of Se obtained from the diet. SM is
converted to H2Se through transulfuration and β-lyase cleavage,
whereas SS interacts with GSH to form GSSeSG which is subsequently
reduced to H2Se. H2Se derived via both pathways can be converted to
selenophosphate which is then used in the synthesis of selenopro-
teins. This difference in Se metabolism is likely to account for the
greater efﬁciency of SS over SM, as has been reported for a variety of
cell types (Zhuo et al., 2009).
Se plays a critical role in testis, sperm, and reproduction. In rodent
testis, Se concentrations are typically higher than for any other tissue
except kidney, and unlike most other tissues except brain and
endocrine tissues, generally do not decrease even with prolonged Se
deﬁciency, showing that Se is preferentially maintained in the rodent
testis (Behne and Höfer-Bosse, 1984; Behne et al., 1988). Selenoprotein
P (Sepp1) is the responsiblemolecule for the targeted trafﬁcking of Se to
testis (Hill et al., 2003; Schomburg et al., 2003). When Se supply is
limited due to Se deﬁciency, incoming Se as Sepp1 would be delivered
preferentially to the Sertoli cells, thereby maintaining testis Se
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drial and cytosolic TrxR, GPx1, andGPx4as themost abundantly present
selenoprotein in rat testis (Maiorino et al., 2006; Roveri et al., 1992;
Tramer et al., 1998). Leydig cells, on the other hand, do not contain
appreciable Sepp1 protein (Olson et al., 2007), but they are the major
cells expressing Sepp1 mRNA in testis (Koga et al., 1998; Steinert et al.,
1998). GPx1 has been implicated in antioxidant defense in Leydig cells
that are presumed to produce H2O2 during steroid hormone synthesis
(Peltola et al., 1996). It is thought that the seminiferous epithelium and
mature sperm also require a particularly efﬁcient protection against
oxidative stress (Tramer et al., 1998; Zini and Schlegel, 1997). GPx1, as
the selenoperoxidase most efﬁcient in H2O2 reduction would indeed be
the enzyme of choice to meet this demand (Ursini et al., 1995).
The induction of GPx1 activity inMA-10 cells that we observedwith
Se supplementation was previously demonstrated in several tissues,
and reported as being due to enhanced translation and not transcription
of the enzyme (Hu and Diamond, 2003). The Se-containing cytosolic
enzyme GPx1 plays an important role in the defense mechanisms of
mammals against damage by catalyzing the reduction of H2O2 and a
large variety of hydroperoxides (Ursini et al., 1995). GPx1, in addition to
affecting GSH/GSSG, controls the cellular content of H2O2 (or other
organic hydroperoxides) and NADPH/NADP+, so that it may regulate
the cellular redox status. Taking into account the critical importance of
GPx1 activity and expression, theGPx1 activity reducing effects of DEHP
(~2.5-fold) and MEHP (~4-fold) shown in this study in MA-10 cells
might be considered as having important implications in testicular
function. Intracellular GSH is a key redox regulator that is crucial for
multiple biological functions. The decrease of GSH we observed in
phthalate treated cells was further supportive of the occurrence of
oxidative stress and disturbance of the intracellular redox equilibrium,
because removal ofH2O2 byGPx1 requiresGSHas a cofactor. Loss of GSH
also occurs through conjugation to endogenous and exogenous
electrophilic centers in reactions catalyzed by GSTs, the enzymes
capable of detoxifying genotoxic electrophilic compounds by catalyzing
their conjugation to GSH, and thus inactivate several environmental
chemicals (Hayes and Pulford, 1995). However, in this study the activity
of cytosolic GST was found to be reduced more than 50% in DEHP, and
MEHP-treated cells, indicating that the phthalate exposure disturbed
the GST expression and/or activity in MA-10 cells as it disturbed GPx1.
Se supplementation was not effective in restoring the GST activity and
even lowered more, a ﬁnding that remained to be explained.
The Trx system, together with TrxR enzymes and NADPH, comprises
an important defense system against oxidative stress and involved in
manybiological processes, suchasDNAmetabolismand repair, apoptosis,
protein folding and degradation, regulation of several transcription
factors and signal transduction (Björnstedt et al., 1997; Watson et al.,
2004). Multiple TrxR enzymes are present, and cytosolic TrxR is a
predominant form known for its antioxidant properties. Like GPx1, it
plays a role in reducing oxidative species either directly or by
regeneration of cellular antioxidants (Xia et al., 2003), and maintain the
redox balance in the cell (Mustacich and Powis, 2000). Available data also
indicate that cytosolic TrxR is regulated by the redox state of the cell
(Gandin et al., 2009), and its speciﬁc activity is highly sensitive to
concentration of Se in cellular milieu. Our ﬁndings showing ~2.4-fold
decrease in cytosolic TrxR activity by both DEHP and MEHP exposures
and signiﬁcant restoration by Se supplementation, thus, provided more
evidence for the alterations of cellular redox state induced by these two
phthalates. Interestingly, protectionbySe supplementationwascomplete
only inMEHP-exposed cells. Our results also suggested thepossibility that
the decrease of TrxR activity contributes to the cytotoxicity of DEHP, and
MEHP in MA-cells, as TrxR is essential for the normal growth of the cell,
and inhibition of TrxR activity to belownormal level has been reported to
cause inhibited cell growth (Mustacich and Powis, 2000).
Various recent data have shown that ROS were involved in the
modulation of cell redox state, and redox regulation of protein
functions is now accepted as an additional regulatory mechanism ofnormal cell physiology (D'Autreaux and Toledano, 2007; Veal et al.,
2007). Thus, ROS recently gained attention as important second
messengers. However, excessive production of ROS may lead to
oxidative stress, loss of cell function, and cell death by apoptosis or
necrosis (Nose, 2000). The increased intracellular ROS production
with phthalate exposure in the current study, along with the
observation of decrease in intracellular GSH level, is the predominant
evidence of a shift in the redox equilibrium towards oxidation, thus
occurrence of oxidative stress. In agreement with our results, Fan et al.
(2010) also observed an increase in ROS generation with MEHP
exposure in MA-10 cells, and demonstrated that the increase of ROS
production even with the highest concentration of MEHP (300 μM)
used in their study was blocked by preincubation of the cells with N-
acetylcysteine (NAC). In this very recent study, the authors suggested
that the MEHP-induced expression of Cyp1a1 might be associated
with the excess ROS generation.
Alteration of cell redox status by ROS can also change thiol groups in
proteins and alter the activation of cell signaling proteins (Dalton et al.,
1999; Finkel, 1998). p53 tumor suppressor protein is one of those
various cell signaling proteins and known to be redox sensitive (Hainaut
and Milner, 1993). When cells are exposed to oxidative stress, p53 is
expressed at high levels by post-translational modiﬁcations (Burns and
El-Deiry, 1999). These modiﬁcations occur rapidly and lead to the
activation of p53, resulting in cell cycle arrest or apoptosis. Therefore,
ROS are reported to function as p53 activators or p53 downstream
effectors (Zhao et al., 2006). In fact, our results showed signiﬁcant
increase in nuclear p53 expression in MEHP-exposed cells further
evidencing the alteration of intracellular redox state by phthalate
exposure. Thus, our data suggested that MEHP, the main metabolite of
DEHP, and possibly at proper doses DEHP itself induce nuclear p53
activation by producing ROS to activate p53. Determination of nuclear
p53 is a good indicator of cell cycle arrest or apoptosis, because after the
transfer of p53 to nucleus or after its overexpression, it is bound to the
promoter regions of several genes including p21, thus, p53 acts as a
transcriptional regulator (Ozturk et al., 2009). The ultimate results of all
these alterations were themodulation of redox sensitive enzymes, DNA
damage as evidenced with the results of alkaline Comet assay, and
decreased cell viability. Our data also showed that, at the dose levels and
formsweused, Se supplementationwasprotective against those adverse
effects of DEHPandMEHP suggesting that Se exerted its protective effect
by regulating the intracellular redox equilibrium of MA-10 cells.
Thus, the results of this study clearly showed the genotoxic potential
of DEHP, and its main metabolite MEHP in MA-10 Leydig cells. This
mighthave a contributory role on theoverall effects of these compounds
which are known as nongenotoxic rodent carcinogens (Rusyn et al.,
2006). On the other hand, Se is known as bimodal in nature. At low
concentrations, Se compounds are antigenotoxic and anticarcinogenic,
whereas at high concentrations, they are mutagenic, toxic, and possibly
carcinogenic (Letavayová et al., 2006). In this regard, it appears that the
doses and the chemical forms of Se we used in this study were
appropriate, did not exert any genotoxicity, but provided protection
against the genotoxic effects of DEHP andMEHPonMA-10 cells at doses
used within the study. The protection of DNA damages by Se might be
through its involvement in DNA repair, but may also be due to a
preventive effect in relation to its intracellular redox modulation.
In conclusion, the overall results of this study demonstrated the
cytotoxicity and genotoxicity of DEHP, and its main metabolite MEHP
in MA-10 mouse Leydig tumor cells indicating the oxidative stress
induction as a main mechanism. Oxidative stress might also be one of
the mechanisms underlying the testicular testosterone suppressing
effect in Leydig cells, and in turn, the reproductive toxicity of DEHP.
Generated data also emphasized the critical role of Se inmodulation of
the redox state in the testicular cells and the importance of the
appropriate Se status. Therefore, it will be meaningful to study the
consequences of oxidative stress on the steroidogenic functions of the
MA-10 Leydig cells and particularly the primary Leydig cells; to
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city, genotoxicity and functional role of those cells; and the regulatory
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